NCT07145879

Brief Summary

The aim of this study is to compare and evaluate the effects of using lidocaine 2% (with adrenaline) and articaine 4% (with adrenaline) in free gingival graft (FGG) surgery on postoperative wound healing, changes in blood flow in the surgical area during the healing process, patients' postoperative pain levels, and anxiety levels before and after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

August 14, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 28, 2025

Completed
Last Updated

August 28, 2025

Status Verified

August 1, 2025

Enrollment Period

7 months

First QC Date

August 14, 2025

Last Update Submit

August 27, 2025

Conditions

Keywords

wound healingfree gingival graftpaindental anxietylocal anaesthesia

Outcome Measures

Primary Outcomes (1)

  • early wound healing score (EHS)

    The healing of the recipient site was evaluated using the EHS index during clinical exams on postoperative days 3, 7, and 14. The EHS index includes parameters of hemostasis (CSH), inflammation (CSI), and re-epithelialization (CSR). The total score ranges from 0 (worst healing) to 10 (best healing)

    3rd day, 7th day, 14th day

Secondary Outcomes (3)

  • Ultrasonographic Evaluations

    3rd, 7th, and 14th days

  • Modified Dental Anxiety Scale (MDAS)

    baseline and 14 days after the procedure,

  • State-Trait Anxiety Inventory (STAI-S and STAI-T)

    baseline and 14 days after the procedure,

Study Arms (2)

lidocaine HCL

OTHER

Participants will receive lidocaine HCL 2% with adrenaline for local anesthesia before free gingival surgery once only

Drug: Lidocaine hydrochloride 2% with epinephrine 1:100 000Procedure: Free gingival graft (FGG)

articaine HCL

OTHER

Participants will receive articaine HCL 4% with adrenaline for local anestesia before free gingival surgery once only

Drug: Articaine 4% with epinephrine 1:100,000Procedure: Free gingival graft (FGG)

Interventions

Patient were received infiltrative anesthesia with Lidocaine (Jetokain, Adeka Ilaç, Samsun, Türkiye): Active ingredient: Each 1 ml contains 20 mg lidocaine hydrochloride (HCL) and 0.012 mg epinephrine base. Excipients: Sodium metabisulfite, sodium chloride, water for injection.

Also known as: free gingival graft
lidocaine HCL

Patients were received Infiltrative anesthesia with Articaine (Ultracain DS Forte, Sanofi Aventis İlaçları, Istanbul, Türkiye): Active ingredient: 40 mg articaine HCL and 0.012 mg epinephrine per 1 ml. Excipients: Sodium chloride, sodium metabisulfite, hydrochloric acid, water for injection

Also known as: free gingival graft
articaine HCL

FGG surgery was performed around natural teeth and implants where keratinized gingival tissue was inadequate.

articaine HCLlidocaine HCL

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients\> 18 years requiring FGG surgery with ≤ 1 mm width of attached gingiva
  • No systemic diseases or pregnancy.
  • Smoking ≤10 cigarettes/day
  • Full-mouth plaque score and full-mouth bleeding score ≤10% (four sites per tooth).
  • Need for FGG due to insufficient attached gingiva
  • No history of mucogingival or periodontal surgery at experimental sites

You may not qualify if:

  • Use of oral contraceptives, psychotropic drugs, sedatives, or NSAIDs
  • Allergy or hypersensitivity to local anesthetics,
  • Orofacial neurological symptoms,
  • Active infection in the surgical area,
  • Pathological mental conditions such as dementia or psychosis, or lack of cooperation,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pamukkale University Faculty of Dentistry

Denizli, 20100, Turkey (Türkiye)

Location

Related Publications (4)

  • Kesici S, Kesici U, Ulusoy H, Erturkuner P, Turkmen A, Arda O. [Effects of local anesthetics on wound healing]. Braz J Anesthesiol. 2018 Jul-Aug;68(4):375-382. doi: 10.1016/j.bjan.2018.01.016. Epub 2018 Jun 6.

    PMID: 29884529BACKGROUND
  • Al-Saffar, M.T., A.S. Mahmood, and M.S. Sulaiman, Impact of Local Anesthesia on Wound Healing. Indian Journal of Forensic Medicine & Toxicology, 2020. 14(4): p. 1869-1874.

    BACKGROUND
  • Giovannitti JA Jr, Rosenberg MB, Phero JC. Pharmacology of local anesthetics used in oral surgery. Oral Maxillofac Surg Clin North Am. 2013 Aug;25(3):453-65, vi. doi: 10.1016/j.coms.2013.03.003. Epub 2013 May 7.

    PMID: 23660127BACKGROUND
  • Luo W, Zheng K, Kuang H, Li Z, Wang J, Mei J. The potential of articaine as new generation of local anesthesia in dental clinics: A review. Medicine (Baltimore). 2022 Dec 2;101(48):e32089. doi: 10.1097/MD.0000000000032089.

    PMID: 36482533BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeHemorrhagePain

Interventions

LidocaineEpinephrineCarticaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsThiophenesSulfur CompoundsHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Aysan Lektemur Alpan, PhD DDS

    Pamukkale University Faculty of Dentistry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
FACTORIAL
Model Details: prospective cross sectional study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Periodontology Department

Study Record Dates

First Submitted

August 14, 2025

First Posted

August 28, 2025

Study Start

January 1, 2025

Primary Completion

July 30, 2025

Study Completion

July 30, 2025

Last Updated

August 28, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

I can share it after my article is published if there is a valid reason.

Locations